Boardroom Alpha
Meeting calendar
SVIA · Annual meeting · Friday, March 27, 2026

Silvia Inc

1 nominee · 4 ballot items.

Approve issuance of shares for the CFO Silvia merger; Elect Eric Jackson as Class I director; Approve amendment to 2025 Equity Incentive Plan to increase share reserve; Approve adjournment of the Annual Meeting if needed to solicit more proxies.

Market cap
$339M
1Y TSR
-68.2%
Board grade
D
Record date
Feb 10, 2026
Filing
DEFM14A
Meeting concluded · Mar 27, 2026

Follow how the vote landed and what changed on Silvia Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot4

  1. 1

    Approval, for purposes of Nasdaq Listing Rule 5635, of the issuance of shares of ProCap’s Common Stock pursuant to the terms of the Merger Agreement

    ManagementBoard: FOR

    Approve issuance of up to 18,000,000 shares of ProCap common stock as merger consideration to acquire CFO Silvia under the Merger Agreement, including escrow and earnout shares and related transfer restrictions, and to satisfy Nasdaq Listing Rule 5635(a)(2).

  2. 2

    Election of Eric Jackson as Class I director

    ManagementBoard: FOR

    Elect Eric Jackson as a Class I director to hold office for a three-year term until the 2029 annual meeting.

  3. 3

    Approval for Equity Plan Amendment

    ManagementBoard: FOR

    Approve an amendment to the Company’s 2025 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by 12,000,000 shares to support compensation and retention.

    More detail

    This management proposal asks shareholders to approve a 12,000,000-share increase to the Company's 2025 Equity Incentive Plan to provide additional capacity for equity awards to employees, executives and directors. Management says the increase is needed to support hiring, retention, and integration in connection with the proposed Merger and ongoing operations, and to align employee incentives with long-term stock performance. The Board and the independent compensation committee considered equity usage, projected hiring and retention needs, dilution, burn rate, and market practices in recommending approval. Management quantifies that approval of the full increase would result in about 14% incremental dilution based on shares outstanding as of the record date; the plan includes usage limits and annual caps to manage overhang. The proposal is routine in the context of an emerging public company seeking to maintain competitive equity programs; the Board recommends a “FOR” vote because it believes equity awards will help retain key talent and align interests with shareholders, while balancing the dilution concerns through plan design and governance controls.

  4. 4

    Approval of possible adjournment of the ProCap Annual Meeting

    ManagementBoard: FOR

    Approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposals 1, 2 or 3.

    More detail

    Management seeks shareholder approval to permit adjournment of the Annual Meeting for up to 30 days to solicit additional proxies if there are insufficient votes to approve the Merger Proposal, the director election, or the Equity Plan Amendment. This is a standard procedural request allowing the Company to continue solicitation efforts to obtain the necessary vote thresholds if initial voting is insufficient by the meeting time. The Board recommends a vote in favor to preserve flexibility to obtain required approvals and avoid having potentially dispositive matters lapse without an opportunity to obtain additional support.

Director elections

Nominees on the ballot1

Ownership

Top institutional holders10

Latest 13F quarter
1LMR Partners LLP4.0%3,534,415$5M
2Magnetar Financial LLC3.5%3,125,000$5M
3K2 PRINCIPAL FUND, L.P.1.9%1,675,800$3M
4CITADEL ADVISORS LLC1.7%1,500,000$2M
5Weiss Asset Management LP1.6%1,388,683$2M
6CSS LLC/IL1.4%1,270,755$2M
7Alyeska Investment Group, L.P.1.4%1,250,000$2M
8Arrington Capital Management, LLC1.4%1,250,000$2M
9BlackRock, Inc.1.2%1,094,314$2M
10SUSQUEHANNA INTERNATIONAL GROUP, LLP1.0%910,550$1M
Filings

Recent key filings

Periodic reports
Reference

Frequently asked questions

When is the Silvia Inc 2026 annual meeting?
Silvia Inc (SVIA) holds its 2026 annual shareholder meeting on Friday, March 27, 2026.
What is the record date for the Silvia Inc 2026 meeting?
The record date for the Silvia Inc 2026 meeting is Tuesday, February 10, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Silvia Inc's 2026 meeting?
The board is presenting 1 director nominee at the Silvia Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Silvia Inc 2026 meeting?
Shareholders will vote on 4 proposals at the Silvia Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer